Simon A. Rothen
Simon Rothen is CEO of sitem-insel AG. He studied biotechnology and bioprocess engineering at ETH Zurich. During his professional career he remained loyal to the life science industry by holding positions at Novartis, Berna Biotech and Medisupport. He is married, has two adult sons and enjoys sporting activities.
Network & Communication
Head of Communication & Marketing
Network & Communication
+41 31 664 60 02
After spending 14 years on the scientific side in various laboratories, Stefanie decided to go for a Ph.D. in neuroscience after which she switched to the other side of the lab bench into marketing, internal organization and communication. She extended her knowledge with an international Executive MBA and now is sitem-insel’s Head of Marketing and Communication. In her free time, she enjoys nature and sports, which she often combines with running or bouldering.
Key Account Manager
+41 31 664 60 14
As Key Account Manager, Sabrina Ilgenstein is the key interface between sitem-insel and its community. She also works as a research assistant at the KPM Center for Public Management of the University of Bern, where she is writing her doctoral thesis in the context of “Strategy Building and Implementation in Public Private Partnerships“ on the case of sitem-insel.
Nadine C. Martin
Head Of Innovation Management
+41 31 664 63 33
Monday, Tuesday, Thursday
Nadine Martin is Head of Innovation Management at sitem-insel AG since 2015. She focusses on activities that inspire an innovation culture for all stakeholders to think and act out of the box and eventually for sitem-insel to stand out as an unique creative and innovative lighthouse. She holds an MD, specialist degrees in Anaesthesiology and in Pharmaceutical Medicine and a certificate in Innovation Management. Nadine has a long standing experience in pharmaceutical industry and served on boards of professional associations, as VP on the Board of LIH and now heads the Scientific Council of the FNR, besides being an expert judge and mentor at MassChallenge Switzerland.
Director Promoting Services
+41 31 664 63 10
Monday - Friday
Rudolf Blankart is Director Promoting Services at sitem-insel AG and Professor of Regulatory Affairs at the KPM Center for Public Management at the University of Bern. Within his role at sitem-insel, he supports the sitem-insel community in regulatory questions concerning the approval of medical technologies. He performs research at the interface of medicine, management, and law and serves as policy expert for national and international public and supranational organizations.
+41 31 664 63 20
Monday - Friday
Kosta Shatrov joined sitem-insel Promoting Services and the KPM Center for Public Management of the University of Bern in September 2017. In his dissertation, he works on the international comparison of health systems of OECD countries. In addition, he examines the economic effects of the regulation of medical devices (MDR).
Director Centralized Services
+41 31 664 60 10
Monday - Friday
As Director Centralized Services, Christian Rosser and his team are responsible for administrative, financial, and operational matters at sitem-insel AG. As secretary of the board of directors and deputy managing director, he also works at the interface between the board of directors and the CEO. As a political scientist by training and expert in Public Administration, Christian Rosser has wide experience in the setup and management of hybrid organizations.
Head Of Finance
+41 31 664 60 13
Anita Newby is assistant to the management of sitem-insel’s Centralized Services. She also works for the KPM Center for Public Management of the University of Bern in a bridging function between sitem-insel and KPM.
Anita Newby holds a BA in Business Administration and has worked in the finance sector for numerous years. After living in England and completing a BSc in Social Sciences she returned to Switzerland with her husband and two children.
Network & Communication
Support Media & Communication
Network & Communication
+31 664 60 07
Tuesday & Thursday
Angela currently studies Media and Communication Science at the University of Fribourg. At sitem-insel she supports the Network & Communication department, mainly in digital related topics and social media. In her free time she enjoys music and does concert photography.
Head of Center of Excellence in Decision-Analytic Modeling and Health Economics Research (CoE DAMHER)
+41 31 664 63 22
Rowan Iskandar is the Head of the Center of Excellence in Decision-Analytic Modeling and Health Economics Research. He holds an Adjunct Assistant Professor of Health Services, Policy, and Practice at Brown University. He is also a scientific collaborator at the Institute of Social and Preventive Medicine. His role at sitem-insel is to aid decision-makers in making better decisions by supporting the evidence generation across the spectrum of a product life-cycle. Within his center, he and his team constantly seek to develop novel methodologies for use in cost-effectiveness analysis and mathematical modeling. He has worked on various diseases, including breast cancer, cervical cancer, HPV, HIV, Alzheimer’s disease, women's health, and rare diseases. He enjoys medium-format photography and watching football.
+41 31 664 63 23
Monday, Wednesday, Thursday, Friday
Lize Duminy joined sitem-insel Promoting Services and the KPM Center for Public Management of the University of Bern in February 2019. Her dissertation focusses on projecting the impact of health policy changes for patients with chronic conditions using simulation modeling. Her interests include quantitative modelling and systems science.
sitem-insel is an independent, non-profit public private partnership. Government funding has been approved for the start-up phase. Subsequently sitem-insel will be financially independent.
Christoph Amman, Minister of Economic Affairs and Member of the Government of the Canton of Bern: national importance, international appeal
The Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel) is a research institution of national importance and international appeal. The project has been designated highest priority by the Swiss Confederation, which is why the Canton of Bern and the federal government will both be supporting the institution from 2017 to 2020 with approximately CHF 25 million each.
The private sector has already recognized the potential of sitem-insel - in fact, the privately funded Diabetes Centre Berne (DCB), under the stewardship of Willy Michel, Chairman of the Board of Directors of the Ypsomed Group, has confirmed that it will be moving to the new sitem-insel building. Major companies such als CSL Behring and Straumann AG are also involved in the project, while other companies are signaling their interest. Furthermore, the new premises will be open to start-ups and spin-offs.
Medical technology, pharmaceuticals and biotechnology are trendsetting branches, and sitem-insel strengthens the innovation potential of these branches, opening up new opportunities and providing the ideal working environment in the field of translational medicine.
Thanks to sitem-insel, the five cantons of Switzerland's Capital Region are taking a major step closer to their goal of expanding their medical location still further and positioning it on the international stage, with a strong medical technology sector and rapidly growing pharmaceutical and biotechnology industries.
The Canton of Bern has established the new legal framework to support this research institution twice as quickly as usual, and granted the building permit in record time. As Minister of Economic Affairs of the Canton of Bern, I remain fully committed to helping maximize sitem-insel's impact.
Prof. Dr. Christian Leumann, Rector University of Bern: sitem-insel offers a unique infrastructure
From the perspective of the University of Bern, founding member of sitem-insel, the new institution offers a unique infrastructure to translate findings from basic research in biomedicine and medical technology into marketable products.
Basic research enjoys high priority at the University of Bern. In the biomedical field, for instance, the University of Bern hosts two National Centers of Competence in Research of the Swiss National Science Foundation - TransCure and RNA & Disease. Both centers aim to develop new treatments for previously untreatable diseases.
The University of Bern is also contributing to optimizing clinical operation technologies from an interdisciplinary perspective with the ARTORG Center for Biomedical Engineering Research and the Institute of Surgical Technology and Biomechanics, ISTB, involving engineers and surgeons. In this context, sitem-insel will complement and intensify existing activities for the benefit of our health care system.
A novelty at sitem-insel are the further training opportunities in the fields of translation, entrepreneurship, and regulatory affairs for medical products. These opportunities are unique in Switzerland's university landscape.
Overall, sitem-insel strengthens the position of the capital region of Bern in the medical sector to take a leading role in Switzerland and in Europe.
Johann N. Schneider-Amman, former Federal Councillor: new perspectives within the health care system
sitem-insel is a future-oriented project. In the new institution, research findings and industrial products are developed into clinical application. This process is called «translation» and involves both industry, basic research, investors and physicians. They are all part of a network in which each member is relevant. Such networks are exactly in the focus of the innovation policy of the Swiss Confederation and in line with the support of the Swiss Innovation Agency Innosuisse.
The Swiss innovation policy neither finances projects top-down nor pays direct subsidies to companies. This policy was successful in the past, a statement backed by Switzerland’s continuous top position in international rankings. The pivotal role of innovation policy for todays economic policy is growing. Our policy calls for collaboration between partners from different industries and research groups and, accordingly for new models of cooperation. This brings us back to sitem-insel, a model project ensuring the involvement of all partners.
The strategy of sitem-insel opens new perspectives within the health care system. I recommend to make use of that opportunity for your own profit in your research projects. Research today is more than ever interdisciplinary and benefits from exchange and cooperation. In the face of limited resources and international competition, a partnership approach is a must.